China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

A spirometry test is one way to distinguish the type of lung disease. Emphysema and chronic bronchitis are both long-term lung conditions. They’re part of a disorder known as chronic obstructive ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow. You may experience breathing difficulties, but you can treat and even prevent flare-ups.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...

In December 1997 the BTS published its first and, to date, only guideline on the management of chronic obstructive pulmonary disease (COPD) in a supplement to Thorax. 1 This was not an evidence based ...

These codes were then used to establish occupational exposures using the ALOHA job exposure matrix. Results: The prevalence of emphysema was 2.4%, chronic obstructive bronchitis 1.8%, and COPD 3.4%.